Tradestie Institutional Equity Comparison Engine
ZGM vs SBC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SBC Overall Edge
SBC Captures Institutional Edge (3โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SBC Medical Group Holdings Incorporated Common Stock (SBC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, ZGM trades at N/M Forward P/E with 31.7% operating margin (-27.0% YoY revenue) versus SBC at 9.0x Forward P/E and 39.9% operating margin (+35.1% YoY). In options structure, ZGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SBC
ZGM N/M vs SBC 9.0x Fwd P/E
Growth & Margin Winner
SBC
Op Margin 31.7% vs 39.9% ยท YoY -27.0% vs +35.1%
Momentum & Technical Winner
SBC
1Y -55.3% vs +63.6% ยท 52W Pos 16% vs 52%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZGM
NASDAQ
Zenta Group Company Limited Ordinary Shares
Services-Management Consulting Services
$1.65
+7.14% 1D
Market Cap
$18.2M
1M Return
-10.81%
1Y Return
-55.28%
Forward P/E
N/M
Unified AI Score
59.4 / 100
HOLD
Tech 60.0
Fund 54.0
Flow 50.0
Mom 50.0
SBC
NASDAQ
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap
$574.4M
1M Return
-9.14%
1Y Return
+63.61%
Forward P/E
9.0x
Unified AI Score
47.2 / 100
HOLD
Tech 41.0
Fund 36.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ZGM -55.28%
SBC +63.61%
Spread: +59.69 pp (SBC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ZGM TTM Op. Margin: 31.7%
SBC TTM Op. Margin: 39.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZGM vs SBC. Trailing 12-month operating profitability (ZGM 31.7% vs SBC 39.9%) and valuation multiples (ZGM N/M vs SBC 9.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZGM | SBC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $18.2M | $574.4M | Larger Scale | SBC |
| Trailing P/E Ratio Valuation | 15.4x | 11.0x | Lower Multiple | SBC |
| Forward P/E Ratio Valuation | N/M | 9.0x | Lower Multiple | SBC |
| Revenue Growth (YoY) Growth | -27.0% | +35.1% | Higher Growth | SBC |
| Operating Margin (TTM) Profitability | 31.7% | 39.9% | Higher Margin | SBC |
| Net Profit Margin Profitability | 31.7% | 27.3% | Higher Margin | ZGM |
| Return on Equity (ROE) Capital Efficiency | 23.4% | 19.3% | Higher ROE | ZGM |
| 52-Week Range Position Momentum | 16% ($1โ$5) | 52% ($3โ$7) | Stronger Trend | SBC |
| Beta / 30D Volatility Risk Regime | 0.88ฮฒ ยท 161% Vol | 0.96ฮฒ ยท 159% Vol | Lower Realized Risk | SBC |
| Unified Institutional Score Composite Signal | 59.4 / 100 (HOLD) | 47.2 / 100 (HOLD) | Higher Composite | ZGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ZGM vs SBC Buy Guide
ZGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SBC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ZGM nor SBC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.